From Launch to Lessons: A Bite-Sized EU HTA First-Year Recap for Market Access
Date: Tuesday 9 December 2025 Time: 11:30 – 12:00 CET Location: Online Exploring the first year of the HTAR implementation. […]
AI in Health Authorities & EU HTA: From Pilot to Strategic Imperative
Author: Florian Stieglitz, Consultant, Market Access Artificial intelligence (AI) is reshaping how regulators, payers, and manufacturers interact with evidence. The Joint
Reimbursement Is Assured, Value Is Negotiated
Reimbursement Is Assured, Value Is Negotiated Author: Tobias Schüning, Consultant Did you know, that when a new drug receives EMA
EMA Approval Timelines – How Long Does it Take From Positive CHMP Opinion to EC Decision?
Author: Malte Glüsen, Senior Research Analyst In the European regulatory landscape, the time between a positive opinion from the Committee
NICE & MHRA Launch Aligned Pathway to Speed Up Access
Author: Ben Barron-Millar, Senior Consultant, Value Communication Kintiga colleagues attended the free webinar hosted by the National Institute for Health
An Innovation Backlog in Germany?
Author: Dr. rer. nat. Florian Stieglitz, Consultant, Germany In a published press release, the German Association of Research-Based Pharmaceutical Companies (Verband
Case Study: Securing AMNOG Alignment for a Drug Launch in Germany
Author: Florian Stieglitz, Market Access Consultant The Kintiga team supported our client to gain a clearer understanding of the legal
NHS 10-Year Plan: What it Means for Pharma and the Future of UK Market Access
Author: Malcolm Boyd, Senior Consultant The NHS England 10-Year Health Plan, published in July 2025, sets out a vision for
Highlights from the Healixia-EUFEMED Conference 2025
Author: Brently Berx, Medical Affairs Officer This month, Kintiga BeNeLux attended the Healixia-EUFEMED joined conference in Belgium: “Mastering increasing complexity
A Global Turning Point for Rare Diseases: What the WHO Resolution Means for Biotech Innovators
Author: Sam Bryant, Regulatory Affairs Manager On 24 May 2025, the World Health Organisation (WHO) adopted a landmark resolution that
